All lobbying filings
Manatt, Phelps, and Phillips
Manatt, Phelps, and Phillips filed a Q3 report for Denali Therapeutics on October 15, 2025, reporting $70,000 in lobbying income.
Lobbying for Denali Therapeutics · Biopharmaceutical Company
Filing · LD-2 quarterly report
Q3 report
Reporting period
3rd Quarter 2025
July 1 - Sep 30 · Posted Oct 15, 2025
Income
$70,000
What the client paid this registrant for the period.
Client based in
California
Lobbying activity
1
Rare Pediatric Disease Priority Review Voucher (PRV) Program Reauthorization; Rare disease drug development